Aditxt (ADTX) Cost of Revenue (2021 - 2026)
Aditxt (ADTX) recorded quarterly Cost of Revenue of $9291.0 in Q1 2026, up 332.57% quarter-over-quarter from -$3995.0 in Q4 2025, and up 1165.8% on a YoY basis from $734.0 in Q1 2025.
Aditxt (ADTX) Cost of Revenue (2021 - 2026) Analysis & Trends
Aditxt's Cost of Revenue history runs 6 years deep, the most recent figure standing at $9291.0 for Q1 2026.
- In Q1 2026, Cost of Revenue rose 1165.8% year-over-year to $9291.0; the TTM figure through Mar 2026 stood at $355059.0 (up 124.6% YoY), while the FY2025 annual figure was $401996.0, up 103.17% from the prior year.
- Cost of Revenue was $9291.0 for Q1 2026 at Aditxt, up from -$3995.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $833942.0 in Q2 2022 to a low of -$3995.0 in Q4 2025.
- Historically, Cost of Revenue has averaged $144972.4 across 5 years, with a median of $103132.0 in 2024.
- Biggest YoY gain for Cost of Revenue was 1341.2% in 2025; the steepest drop was 103.87% in 2025.
- A 5-year view of Cost of Revenue shows it stood at $170166.0 in 2022, then soared by 67.99% to $285867.0 in 2023, then plunged by 63.92% to $103132.0 in 2024, then sank by 103.87% to -$3995.0 in 2025, then surged by 332.57% to $9291.0 in 2026.
- The last three Cost of Revenue figures came in at $9291.0 (Q1 2026), -$3995.0 (Q4 2025), and $732.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 64.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 48,670.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 392.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 2.05 Mn |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | 9,291.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,291.00 |
| Mar 31, 2026 | 9,291.00 |
| Dec 31, 2025 | -3,995.00 |
| Dec 31, 2025 | -3,995.00 |
| Sep 30, 2025 | 732.00 |
| Sep 30, 2025 | 732.00 |
| Jun 30, 2025 | 349,031.00 |
| Jun 30, 2025 | 349,031.00 |
| Mar 31, 2025 | 734.00 |
| Mar 31, 2025 | 734.00 |
| Dec 31, 2024 | 103,132.00 |
| Dec 31, 2024 | 103,132.00 |
| Sep 30, 2024 | 30,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Jun 30, 2024 | 24,218.00 |
| Jun 30, 2024 | 24,218.00 |
| Mar 31, 2024 | 65,799.00 |
| Mar 31, 2024 | 65,799.00 |
| Dec 31, 2023 | 285,867.00 |
| Dec 31, 2023 | 285,867.00 |